Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Resistin enhances the expansion of regulatory T cells through modulation of dendritic cells.

Son YM, Ahn SM, Kim GR, Moon YS, Kim SH, Park YM, Lee WK, Min TS, Han SH, Yun CH.

BMC Immunol. 2010 Jun 30;11:33. doi: 10.1186/1471-2172-11-33.

2.

Experimental endotoxemia induces adipose inflammation and insulin resistance in humans.

Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, Tabita-Martinez J, Sellers KF, Rickels MR, Reilly MP.

Diabetes. 2010 Jan;59(1):172-81. doi: 10.2337/db09-0367. Epub 2009 Sep 30.

3.

Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters.

Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J, Goldfine AB, Benoist C, Shoelson S, Mathis D.

Nat Med. 2009 Aug;15(8):930-9. doi: 10.1038/nm.2002. Epub 2009 Jul 26.

4.

Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients.

Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C.

Crit Care. 2009;13(3):R95. doi: 10.1186/cc7925. Epub 2009 Jun 19.

5.

Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor kappa b pathway.

Raetzsch CF, Brooks NL, Alderman JM, Moore KS, Hosick PA, Klebanov S, Akira S, Bear JE, Baldwin AS, Mackman N, Combs TP.

Hepatology. 2009 Aug;50(2):592-600. doi: 10.1002/hep.22999.

6.

Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells.

Luo Z, Zhang Y, Li F, He J, Ding H, Yan L, Cheng H.

Endocrine. 2009 Aug;36(1):60-9. doi: 10.1007/s12020-009-9198-7. Epub 2009 May 8.

PMID:
19440859
7.

Lipopolysaccharide (LPS) stimulates adipokine and socs3 gene expression in mouse brain and pituitary gland in vivo, and in N-1 hypothalamic neurons in vitro.

Brown R, Imran SA, Wilkinson M.

J Neuroimmunol. 2009 Apr 30;209(1-2):96-103. doi: 10.1016/j.jneuroim.2009.02.001. Epub 2009 Mar 3.

PMID:
19261336
8.

Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.

Qatanani M, Szwergold NR, Greaves DR, Ahima RS, Lazar MA.

J Clin Invest. 2009 Mar;119(3):531-9. doi: 10.1172/JCI37273. Epub 2009 Feb 2.

9.

Effects of resistin expression on glucose metabolism and hepatic insulin resistance.

Li FP, He J, Li ZZ, Luo ZF, Yan L, Li Y.

Endocrine. 2009 Apr;35(2):243-51. doi: 10.1007/s12020-009-9148-4. Epub 2009 Jan 31.

PMID:
19184634
10.

Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding proteins.

Tomaru T, Steger DJ, Lefterova MI, Schupp M, Lazar MA.

J Biol Chem. 2009 Mar 6;284(10):6116-25. doi: 10.1074/jbc.M808407200. Epub 2009 Jan 5.

11.

Sphingolipids: players in the pathology of metabolic disease.

Cowart LA.

Trends Endocrinol Metab. 2009 Jan;20(1):34-42. doi: 10.1016/j.tem.2008.09.004. Epub 2008 Nov 13. Review.

PMID:
19008117
12.

Early endotoxemia increases peripheral and hepatic insulin sensitivity in healthy humans.

van der Crabben SN, Blümer RM, Stegenga ME, Ackermans MT, Endert E, Tanck MW, Serlie MJ, van der Poll T, Sauerwein HP.

J Clin Endocrinol Metab. 2009 Feb;94(2):463-8. doi: 10.1210/jc.2008-0761. Epub 2008 Nov 4.

PMID:
18984669
13.

Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance.

Hivert MF, Sullivan LM, Fox CS, Nathan DM, D'Agostino RB Sr, Wilson PW, Meigs JB.

J Clin Endocrinol Metab. 2008 Aug;93(8):3165-72. doi: 10.1210/jc.2008-0425. Epub 2008 May 20.

14.

Homocysteine upregulates resistin production from adipocytes in vivo and in vitro.

Li Y, Jiang C, Xu G, Wang N, Zhu Y, Tang C, Wang X.

Diabetes. 2008 Apr;57(4):817-27. doi: 10.2337/db07-0617. Epub 2008 Jan 11.

15.

Resistin- and Obesity-associated metabolic diseases.

Lazar MA.

Horm Metab Res. 2007 Oct;39(10):710-6. Review.

PMID:
17952831
16.

Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide.

Imai Y, Varela GM, Jackson MB, Graham MJ, Crooke RM, Ahima RS.

Gastroenterology. 2007 May;132(5):1947-54. Epub 2007 Feb 23.

PMID:
17484887
17.

Metabolic endotoxemia initiates obesity and insulin resistance.

Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R.

Diabetes. 2007 Jul;56(7):1761-72. Epub 2007 Apr 24.

18.

Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock.

Sundén-Cullberg J, Nyström T, Lee ML, Mullins GE, Tokics L, Andersson J, Norrby-Teglund A, Treutiger CJ.

Crit Care Med. 2007 Jun;35(6):1536-42.

PMID:
17452927
19.

Innate immunity modulates adipokines in humans.

Anderson PD, Mehta NN, Wolfe ML, Hinkle CC, Pruscino L, Comiskey LL, Tabita-Martinez J, Sellers KF, Rickels MR, Ahima RS, Reilly MP.

J Clin Endocrinol Metab. 2007 Jun;92(6):2272-9. Epub 2007 Mar 20.

PMID:
17374708
20.

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance.

Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y, Narra K, Hoehn KL, Knotts TA, Siesky A, Nelson DH, Karathanasis SK, Fontenot GK, Birnbaum MJ, Summers SA.

Cell Metab. 2007 Mar;5(3):167-79.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk